氨甲环酸对休克条件下血小板黏附于内皮的影响:一种保护作用?
本文为体外微流控内皮细胞培养研究,将内皮细胞置于流动条件下,分为对照与缺氧-肾上腺素暴露组,并在不同时间点向灌注液中加入氨甲环酸。结果显示,氨甲环酸可保护内皮糖萼免受缺氧-复氧-肾上腺素暴露后的降解,并以时间敏感方式显著减少血小板黏附于内皮。作者据此认为,氨甲环酸可能通过抑制血小板黏附、减轻内皮血栓炎症,保护休克后的微循环灌注异常。
要点
- 在微流控内皮细胞培养模型中,氨甲环酸可保护内皮糖萼免受缺氧-复氧-肾上腺素暴露后的降解。
- 氨甲环酸以时间敏感方式显著减少休克条件下血小板黏附于内皮。
- 作者认为氨甲环酸可能通过抑制血小板黏附、减轻内皮血栓炎症,保护休克后的微循环灌注异常。
- 上述结果来自体外微流控模型,而非临床或动物在体研究。
适用人群与场景
- 体外微流控内皮细胞培养模型,暴露于流动条件,分对照与缺氧-肾上腺素暴露组。
处置流程与药物剂量
- 在对照与实验组的灌注液中,于不同时间点加入氨甲环酸;原文未给出具体剂量、浓度、给药途径与时间点。
研究设计与关键结果
- 研究类型:体外微流控内皮细胞培养模型研究,在受控微环境中进行。
- 干预与对照:内皮细胞培养暴露于流动条件,分对照或缺氧-肾上腺素暴露;氨甲环酸于不同时间点加入对照与实验组的灌注液。
- 主要终点:氨甲环酸在缺氧-复氧-肾上腺素暴露后保护糖萼免受降解;氨甲环酸以时间敏感方式显著减少血小板黏附于内皮。
证据类型、等级与局限
- 证据类型:体外微流控细胞培养模型研究(转化研究)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,氨甲环酸可能保护微血管免受休克后的灌注异常,这很可能源于抑制血小板黏附并减轻微血管内皮处的血栓炎症。
- 上述为体外模型结果,原文未据此给出临床用药推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
INTRODUCTION: Trauma and hemorrhagic shock lead to microcirculatory disturbances related to endothelial injury and endothelial glycocalyx (EG) degradation. Improved outcomes following trauma and hemorrhagic shock have been linked to protection of the EG layer, which is a topic of increasing investigation. Early tranexamic acid (TXA) administration following trauma and hemorrhagic shock improves outcomes in clinic studies. Recent translational studies have also shown that early TXA administration protects the EG following shock insults; the impact on blood-endothelial cell interactions is unknown. Platelet adherence to vascular endothelium may contribute to microcirculatory disturbances; the effects of TXA on this phenomenon are uncertain. Microfluidic devices have been used to study the behavior of endothelial cells and platelets under flow conditions. We hypothesize that the protective effect of TXA against EG degradation would prevent shock-induced platelet adhesion to the microvasculature. This was studied in a microfluidic cell culture model under a controlled microenvironment.
METHODS: Microfluidic endothelial cell cultures were exposed to flow conditions under control or hypoxia-epinephrine exposure. Tranexamic acid was added to the perfusate at various times in control and experimental groups. Endothelial glycocalyx thickness, degradation products, and platelet adhesion to the endothelium were measured.
RESULTS: Tranexamic acid protected the glycocalyx from degradation following hypoxia-reoxygenation-epinephrine exposure. Platelet adhesion to the endothelium was significantly reduced by TXA in a time sensitive manner.
CONCLUSION: Tranexamic acid may protect the microvasculature from perfusion abnormalities following shock conditions. This is likely due to inhibition of platelet adhesion and mitigating thromboinflammation at the endothelium in the microvasculature.
参考来源
- Karadjoff A, Liberati DM, Diebel LN, et al. Tranexamic acid impact on platelet adhesion to the endothelium after shock conditions: A protective effect? J Trauma Acute Care Surg. 2025. PMID: 39945544. doi:10.1097/TA.0000000000004572
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。